Literature DB >> 2869226

HTLV-III antibodies in patients with kidney transplants or on haemodialysis.

H H Neumayer, K Wagner, S Kresse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2869226     DOI： 10.1016/s0140-6736(86)92948-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis.

Authors:  R A Baillod; S F Lui; P Sweny; M G Ross; P D Griffiths; J Grundy; J F Moorhead
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

2.  AIDS virus antibody in polytransfused dialysis patients vaccinated against hepatitis B.

Authors:  J Desmyter; M Reynders; P Goubau
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

3.  Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis.

Authors:  M Goldman; C Liesnard; J L Vanherweghem; N Dolle; C Toussaint; S Sprecher; J Cogniaux; L Thiry
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-19

Review 4.  Transmission of human immunodeficiency virus (HIV/HTLV-III/LAV): a review.

Authors:  M van der Graaf; R J Diepersloot
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

Review 5.  Infections and immunological hazards of allogeneic bone transplantation.

Authors:  G O Hofmann; M H Kirschner; T Wangemann; C Falk; W Mempel; C Hammer
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.